BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19377508)

  • 1. Overexpression of an activated REL mutant enhances the transformed state of the human B-lymphoma BJAB cell line and alters its gene expression profile.
    Chin M; Herscovitch M; Zhang N; Waxman DJ; Gilmore TD
    Oncogene; 2009 May; 28(20):2100-11. PubMed ID: 19377508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The NF-κB subunit c-Rel regulates Bach2 tumour suppressor expression in B-cell lymphoma.
    Hunter JE; Butterworth JA; Zhao B; Sellier H; Campbell KJ; Thomas HD; Bacon CM; Cockell SJ; Gewurz BE; Perkins ND
    Oncogene; 2016 Jun; 35(26):3476-84. PubMed ID: 26522720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NF-kappaB down-regulates expression of the B-lymphoma marker CD10 through a miR-155/PU.1 pathway.
    Thompson RC; Herscovitch M; Zhao I; Ford TJ; Gilmore TD
    J Biol Chem; 2011 Jan; 286(3):1675-82. PubMed ID: 20947507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.
    Garbati MR; Alço G; Gilmore TD
    Cancer Lett; 2010 May; 291(2):237-45. PubMed ID: 19948376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for assessing the in vitro transforming activity of NF-κB transcription factor c-Rel and related proteins.
    Gilmore TD; Gélinas C
    Methods Mol Biol; 2015; 1280():427-46. PubMed ID: 25736765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NFkappaB activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes.
    Feuerhake F; Kutok JL; Monti S; Chen W; LaCasce AS; Cattoretti G; Kurtin P; Pinkus GS; de Leval L; Harris NL; Savage KJ; Neuberg D; Habermann TM; Dalla-Favera R; Golub TR; Aster JC; Shipp MA
    Blood; 2005 Aug; 106(4):1392-9. PubMed ID: 15870177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative and canonical NF-kB pathways DNA-binding hierarchies networks define Hodgkin lymphoma and Non-Hodgkin diffuse large B Cell lymphoma respectively.
    Gamboa-Cedeño AM; Castillo M; Xiao W; Waldmann TA; Ranuncolo SM
    J Cancer Res Clin Oncol; 2019 Jun; 145(6):1437-1448. PubMed ID: 30941572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAFF-R promotes cell proliferation and survival through interaction with IKKbeta and NF-kappaB/c-Rel in the nucleus of normal and neoplastic B-lymphoid cells.
    Fu L; Lin-Lee YC; Pham LV; Tamayo AT; Yoshimura LC; Ford RJ
    Blood; 2009 May; 113(19):4627-36. PubMed ID: 19258594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma.
    Li L; Xu-Monette ZY; Ok CY; Tzankov A; Manyam GC; Sun R; Visco C; Zhang M; Montes-Moreno S; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Møller MB; Wang J; Parsons BM; Winter JN; Piris MA; Pham LV; Medeiros LJ; Young KH
    Oncotarget; 2015 Sep; 6(27):23157-80. PubMed ID: 26324762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Oncogenic Transcription Factor REL by the Natural Product Derivative Calafianin Monomer 101 Induces Proliferation Arrest and Apoptosis in Human B-Lymphoma Cell Lines.
    Yeo AT; Chennamadhavuni S; Whitty A; Porco JA; Gilmore TD
    Molecules; 2015 Apr; 20(5):7474-94. PubMed ID: 25915462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-XL, but not Bcl-2, can protect human B-lymphoma cell lines from parthenolide-induced apoptosis.
    Yeo AT; Porco JA; Gilmore TD
    Cancer Lett; 2012 May; 318(1):53-60. PubMed ID: 22155272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IKK2/NF-{kappa}B pathway suppresses MYC-induced lymphomagenesis.
    Klapproth K; Sander S; Marinkovic D; Baumann B; Wirth T
    Blood; 2009 Sep; 114(12):2448-58. PubMed ID: 19628709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of the IL-21 gene by the NF-κB transcription factor c-Rel.
    Chen G; Hardy K; Bunting K; Daley S; Ma L; Shannon MF
    J Immunol; 2010 Aug; 185(4):2350-9. PubMed ID: 20639489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of gene expression in T cells to identify targets of the NF-kappa B transcription factor c-Rel.
    Bunting K; Rao S; Hardy K; Woltring D; Denyer GS; Wang J; Gerondakis S; Shannon MF
    J Immunol; 2007 Jun; 178(11):7097-109. PubMed ID: 17513759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of IKBA coding region mutations in primary mediastinal large B-cell lymphoma and the host response subtype of diffuse large B-cell lymphoma.
    Takahashi H; Feuerhake F; Monti S; Kutok JL; Aster JC; Shipp MA
    Blood; 2006 Jan; 107(2):844-5. PubMed ID: 16401828
    [No Abstract]   [Full Text] [Related]  

  • 17. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms.
    Parekh S; Polo JM; Shaknovich R; Juszczynski P; Lev P; Ranuncolo SM; Yin Y; Klein U; Cattoretti G; Dalla Favera R; Shipp MA; Melnick A
    Blood; 2007 Sep; 110(6):2067-74. PubMed ID: 17545502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the transcriptional function of the NF-κB protein c-Rel by O-GlcNAc glycosylation.
    Ramakrishnan P; Clark PM; Mason DE; Peters EC; Hsieh-Wilson LC; Baltimore D
    Sci Signal; 2013 Aug; 6(290):ra75. PubMed ID: 23982206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant transformation of primary chicken spleen cells by human transcription factor c-Rel.
    Gilmore TD; Cormier C; Jean-Jacques J; Gapuzan ME
    Oncogene; 2001 Oct; 20(48):7098-103. PubMed ID: 11704834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.